Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ – STARS Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc to acquire Precision Dermatology Inc

Monday, 3 Feb 2014 08:01am EST 

Valeant Pharmaceuticals International Inc:Enters into a definitive agreement under which Valeant will acquire PreCision Dermatology, Inc.Says for a consideration $475 mln in cash, plus an additional $25 mln payable upon the achievement of a sales.Says the transaction is expected to close in the first half of 2014.Says J.P. Morgan Securities LLC acted as exclusive financial advisor to PreCision, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor to PreCision.Says Sullivan & Cromwell LLP acted as legal advisor to Valeant.